Cyclacel Pharmaceuticals, Inc. (CYCC) - NASDAQ
Company Description
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail... More
Sector: Healthcare
Industry: Biotechnology
Country: United States